Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Catalytic Ambient Temperature Dinitrogen Conversion to a Bis(silyl)amine by Mononuclear Group 4 Aryloxide Complexes.

Inorganic chemistry·2026
Same author

Training for the Digital Clinical Environment: Preliminary Findings in Implementation of Electronic Health Record Platform in Medical Education.

Journal of medical systems·2026
Same author

Uranyl Tris(benzoate) Photocatalysts for Site-Selective Hydrocarbon Functionalization.

Journal of the American Chemical Society·2026
Same author

Real-world management and outcomes of immune-mediated diarrhea and colitis: gaps in guideline adherence and opportunities for implementation.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Machine learning-guided optimization of triple agonist peptide therapeutics for metabolic disease.

Frontiers in bioinformatics·2025
Same author

Loss of ADAM17 in smooth muscle cells enhances their transformation to macrophage-like cells leading to more severe atherosclerosis in mice.

Atherosclerosis·2025

Related Experiment Videos

Using a diabetes data mart in individualizing diabetes management.

Youssef T Al-sheikh1, Peter J Haug, Anthony Wong

  • 1Department of Biomedical Informatics, School of Medicine, University of Utah, SLC, UT, USA.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|November 13, 2008
PubMed
Summary

Personalized diabetes management is now possible using electronic medical records. A new hybrid system adapts insulin treatment to individual patient needs, tested on 33,000 patients.

Related Experiment Videos

Area of Science:

  • Endocrinology
  • Computational Biology
  • Health Informatics

Background:

  • Diabetes care standards are dynamic, complicating individualized patient treatment.
  • Electronic medical records (EMRs) offer vast data for personalized diabetes management.

Purpose of the Study:

  • To present the initial design of a patient-specific hybrid system for adaptive diabetes management.
  • To develop adaptive diabetes models and insulin treatment algorithms tailored to individual patients.

Main Methods:

  • Development of a hybrid system combining physiological-causal probabilistic models.
  • Utilizing a large-scale diabetes data mart (approx. 33,000 patients) for system derivation and testing.

Main Results:

  • The presented system is designed for patient-specific adaptation.
  • The system's feasibility is demonstrated through testing on a substantial patient dataset.

Conclusions:

  • A patient-specific hybrid system offers a novel approach to individualize diabetes care.
  • Leveraging EMR data is crucial for developing advanced, adaptive diabetes management tools.